Pharmaceutical Industries Ltd.
Your browser does not support iframes.
See Teva's sites around the world
Japan & S. Korea
Bosnia & Herzegovina
Want to find out more about Teva's locations and phone numbers?
Visit Teva Worldwide
Board of Directors
2017 Annual Report – Form 10-K
Notice of Annual Meeting of Shareholders 2017 – Proxy Statement
Over the Counter (OTC)
Central Nervous System (CNS)
National Network of Excellence
Position on Antimicrobial Resistance (AMR)
2016 Social Impact Report
Previous CSR Reports
Supplier Code of Conduct & Information for Our Suppliers
Global Patient Organization and Advocacy Disclosure
Four New Independent Directors Join the Teva Board
Webcasts and Presentations
Dare to be different
Our Guiding Values
Working at Teva
Grow with the Best
Corporate Governance Documents
Go to Parent
Teva Global Anti-Corruption Policy
Board of Directors
Transparency and Ethical Business Practice
We know that our patients, and all stakeholders seek assurance that Teva acts lawfully, ethically and responsibly, and increasingly, stakeholders are transparent about our business practices and not only our medicines.
Share on Facebook
Share on LinkedIn
Share on Twitter
We aim to maintain the trust of our stakeholders in our company and our people by upholding high standards of responsible and ethical behavior. This includes maintaining a culture of ethics and compliance and ensuring our approach is embedded throughout our supply chain. Each year, we aim to increase the transparency of our practices to ensure all our stakeholders can make informed decisions.
Governance, ethics and transparency highlights in 2015
Engaged 100% of our newly hired employees worldwide to complete a training course in our Code of Conduct achieving a 93% completion rate.
Engaged 100% of our eligible newly hired employees worldwide to complete our Anti-Corruption training course, achieving a 97% completion rate.
Complied with Medicines for Europe’s industry Code of Conduct on Interactions with the Healthcare Community published in February 2015.
Completed 46 country audits and tested almost 5,500 transactions in more than 35 countries via our Global Internal Audit department in 2014 and 2015.
Raised awareness of our Teva Integrity Hotline with 1,400 posters to 46 countries in 38 languages.
Reported with disclosures from the Global Reporting Initiative (GRI) G4 sustainability reporting standards.
Complied with our commitment to submit an annual Communication on Progress to the UN Global Compact.